(Q54638945)

1 June 2018

reason for preferred rank

title

A double-blind evaluation of zimelidine in comparison to placebo and amitmptyline in patients with major depressive disorder (English)

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

1 September 2023

A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

1 September 2023

1

Claghorn J

1 reference

1 June 2018

author name string

J. Claghorn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

S. Gershon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

B. J. Goldstein

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

S. Behrnetz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

D. F. Bush

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

B. Huitfeldt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6225150

1 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6225150

1 September 2023

publication date

1 January 1983

1 reference

1 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0278584683901252?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

https://api.elsevier.com/content/article/PII:0278584683901252?httpAccept=text/plain

1 September 2023

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

Progress in Neuro-Psychopharmacology & Biological Psychiatry

1 September 2023

published in

1 reference

1 June 2018

volume

7

1 reference

1 June 2018

issue

2-3

1 reference

1 June 2018

page(s)

367-382

1 reference

1 June 2018

A double?blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients

1 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

Zimelidine: A therapeutic and pharmacokinetic study in depression

1 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

A rating scale for depression

1 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

Cardiovascular effects of zimelidine and other antidepressant in conscious rats

1 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

A double blind comparison of zimelidine and amitriptyline in endogenous depression

1 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

Effects of zimelidine on serotoninergic and noradrenergic neurons after repeated administration in the rat

1 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0278-5846(83)90125-2

1 September 2023

Identifiers

1 reference

1 June 2018

1 reference

1 June 2018